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Pollen grains induce allergies in susceptible individuals by release of allergens upon contact 
with mucosal membranes of the upper respiratory tract. We recently demonstrated that 
pollen not only function as allergen carriers but also as rich sources of bioactive lipids that 
attract cells involved in allergic inflammation such as neutrophils and eosinophils. Here we 
demonstrate that soluble factors from birch (
 
Betula alba
 
 L.) pollen activate human dendritic 
cells (DCs) as documented by phenotypical and functional maturation and altered cytokine 
production. 
 
Betula alba
 
 L. aqueous pollen extracts (
 
Bet.
 
-APE) selectively inhibited 
interleukin (IL)-12 p70 production of lipopolysaccharide (LPS)- or CD40L-activated DC, 
whereas IL-6, IL-10, and TNF
 
 
 
 remained unchanged. Presence of 
 
Bet.
 
-APE during DC 
activation resulted in DC with increased T helper type 2 (Th2) cell and reduced Th1 cell 
polarizing capacity. Chemical analysis of 
 
Bet.-
 
APE revealed the presence of phytoprostanes 
(dinor isoprostanes) with prostaglandin E
 
1
 
-, F
 
1
 
-, A
 
1
 
-, or B
 
1
 
-ring systems of which only 
E
 
1
 
-phytoprostanes dose dependently inhibited the LPS-induced IL-12 p70 release and 
augmented the Th2 cell polarizing capacity of DC. These results suggest that pollen-derived 
E
 
1
 
-phytoprostanes not only resemble endogenous prostaglandin E
 
2
 
 structurally but also 
functionally in that they act as regulators that modulate human DC function in a fashion 
that favors Th2 cell polarization.
 
Atopic diseases are characterized by a predomi-
nance of Th2-biased immune responses to en-
vironmental allergens (1). Allergen-specific Th2
cells are the key orchestrators of allergic reac-
tions, initiating and propagating inflammation
through the release of a number of Th2 cyto-
kines such as IL-4, which regulates isotype switch-
ing to allergen-specific IgE (2), or IL-5, which
recruits and activates eosinophils (3). Whereas
the biology of Th2 cells in allergy is well under-
stood, little is known about the mechanisms that
control the initial Th2 polarization in response to
exogenous allergens. Some studies suggest aller-
gen-dependent mechanisms determined at the
DC level due to particular attributes of the spe-
cific protein (4–6). Others suggest T cell–depen-
dent (7) or individual (8, 9) factors leading to a
predominance of the Th2 response.
DCs are pivotal in the initiation of adaptive
immune responses (10). They produce IL-12
(one of the crucial Th1-polarizing cytokines)
upon activation by pathogen-associated mo-
lecular patterns such as LPS (11) or by T cell–
derived signals such as CD40 ligation (12).
However, simultaneous presence of endoge-
nous signals such as IL-10, TGF
 
 
 
, corticoste-
roids, vitamin D
 
3
 
, or PGE
 
2
 
 can convert DCs
from Th1- to Th2-skewing antigen presenting
cells (13, 14). Recent studies also demonstrate
that exogenous factors such as lipids produced
by parasites can modulate DC function for
the purposes of evading host immunity (15).
These observations have generated a growing
interest in defining how and which additional
exogenous signals may regulate DC function
in a fashion that may result in an altered
generation of Th1- versus Th2-dominated
immunity.
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In the context of allergy, pollen grains have simply been
regarded as allergen carriers, and little attention has been de-
voted to nonprotein compounds of pollen. However, individ-
uals are rarely exposed to pure allergens, but rather to particles
releasing the allergen such as pollen grains or pollen-derived
granules (16–18). Notably, lipids are major components of
pollen excine and exsudate (17). In addition, long chain unsat-
urated fatty acids in pollen, such as linolenic acid, serve as pre-
cursors for the biosynthesis of several plant hormones such as
dinor isoprostanes, recently termed phytoprostanes (19–21).
Phytoprostanes are formed nonenzymatically via autooxida-
tion in plants and structurally resemble prostaglandins and iso-
prostanes in humans (22, 23). Recent results suggest that phy-
toprostanes might have an evolutionary ancient function in
plant host defense (22, 23). Whereas the physiological role of
phytoprostanes in the life cycle of plants is just beginning to
emerge, virtually nothing is known about their effects on the
human immune response in health and disease.
We demonstrated recently that pollen, under physiologi-
cal exposure conditions, release not only allergens but also
bioactive lipids that activate human neutrophils and eosino-
phils in vitro (24–26). Here we describe the ability of aque-
ous birch pollen extracts (
 
Bet.
 
-APE) to affect maturation and
cytokine release of human DCs that results in an increased
capacity to induce Th2 responses in naive T cells. By means
of negative chemical ionization gas chromatography-mass
spectrometry (NCI GC-MS) analysis of 
 
Bet.
 
-APE, we dem-
onstrate the presence of E
 
1
 
-, F
 
1
 
-, and A
 
1
 
/B
 
1
 
-phytoprostanes
and show that E
 
1
 
-phytoprostanes (similar to 
 
Bet.
 
-APE) dose
dependently inhibit IL-12 production and induce an in-
creased Th2-polarizing capacity of human DCs. To the best
of our knowledge, this represents the first study demonstrat-
ing that plant isoprostanes can affect the outcome of mam-
malian immune responses.
 
RESULTS
Induction of phenotypic and functional DC maturation 
by 
 
Bet.
 
-APE
 
To investigate the impact of soluble factors released from
pollen on the function of human DCs, immature monocyte-
derived DCs were exposed to 
 
Bet.-
 
APE and phenotypical
and functional DC maturation was analyzed. Analysis of
 
Bet.
 
-APE by 
 
Limulus
 
 amebocyte lysate (LAL) test revealed
substantial quantities of LPS (ranging from 10 to 500 EU/
ml). Elution over polymyxin B columns allowed efficient re-
moval of LPS (
 
 
 
0.05 EU/ml). LPS-depleted 
 
Bet.
 
-APE was
used for all subsequent experiments. Exposure of immature
DCs to 
 
Bet.-
 
APE alone induced an up-regulation of HLA-
DR surface expression, whereas the remaining maturation
markers (CD40, CD80, CD83, and CD86) remained un-
changed (Fig. 1). When DCs were stimulated simultaneously
with LPS plus 
 
Bet
 
.-APE, the presence of 
 
Bet.
 
-APE resulted
in an additional up-regulation effect of CD80, CD86, and
HLA-DR surface expression (Fig. 1). The change in surface
marker expression was also reflected at a functional level
when analyzing the allostimulatory capacity of DCs in MLR.
Exposure of immature DCs to 
 
Bet
 
.-APE alone resulted in an
enhanced proliferative response of allogeneic naive T cells
(Fig. 2, A and B). Simultaneous DC stimulation with 
 
Bet
 
.-
APE and LPS appeared to cause additive effects (Fig. 2, A
and B). The effect of 
 
Bet
 
.-APE on the allostimulatory activ-
ity was dose dependent (Fig. 2 B).
Figure 1. Bet.-APE effects on DC maturation. Immature DCs were 
left untreated (medium), stimulated with LPS (100 ng/ml) or LPS-depleted 
Bet.-APE (1 mg/ml), or simultaneously with both stimuli. Surface marker 
expression was analyzed after 24 h using flow cytometry. Medium control 
DCs (thin line) served as reference for all other culture conditions (bold 
line). Numbers indicate the net mean fluorescence intensity. Representa-
tive experiment of n   5 using DCs from different nonatopic donors.
Figure 2. Bet.-APE induce DCs allostimulatory activity. (A) Immature 
DCs were left untreated (medium) or stimulated with LPS (100 ng/ml), 
Bet.-APE (3 mg/ml) alone, or together with LPS (100 ng/ml). After 24 h, 
DCs were analyzed for their capacity to induce T cell proliferation in naive 
allogeneic CD4  CD45RA  T lymphocytes (105/well). (B) DCs (2.5   104) 
stimulated with graded concentrations of Bet.-APE alone or together with 
LPS (100 ng/ml) were coincubated with naive T cells. T cell proliferation 
was measured by BrDU incorporation after 3 d of coculture. Results are 
given as mean OD   SD of triplicate cultures and are representative of 
five independent experiments from different nonatopic donors.  
JEM VOL. 201, February 21, 2005
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Bet.-
 
APE inhibits DC IL-12 production
 
Under control conditions (medium) DCs spontaneously re-
leased low levels of IL-12 (43.4
 
   
 
18.4 pg/ml, 
 
n
 
 
 
  
 
6), IL-6
(393
 
   
 
280 pg/ml), TNF
 
 
 
 (
 
 
 
78 pg/ml, 
 
n
 
   
 
6), and IL-10
(11.8
 
   
 
5.3 pg/ml, 
 
n
 
   
 
5). LPS stimulation induced an up-
regulation of these cytokines 82-, 33-, 40-, and 29- fold,
respectively. Interestingly, 
 
Bet.
 
-APE when added simulta-
neously with LPS dose-dependently inhibited LPS-induced
IL-12 p70 release, although it had no significant effect on
basal IL-12 production (unpublished data). In contrast, LPS-
induced IL-6, IL-10, and TNF-
 
 
 
 release was not affected
(Fig. 3
 
 
 
A). The inhibition of IL-12 p70 was not due to cyto-
toxic effects as determined by propidium iodide staining.
 
Bet.
 
-APE similarly inhibited the IL-12 p70 production when
DCs were activated by CD40 ligation (unpublished data).
IL-12 is a heterodimeric cytokine, consisting of cova-
lently bound p40 and p35 subunits (27). Distinct genes en-
code each subunit and each gene is independently regulated.
To investigate the effects of 
 
Bet
 
.-APE on IL-12 p40 and p35
mRNA expression DCs were stimulated with LPS in the
presence or absence of increasing concentrations of 
 
Bet
 
.-
APE. LPS stimulation resulted in a strong induction of IL-12
p40 mRNA ([2
 
{
 
   
 
CT}
 
]: 1,149 
 
 
 
 518, 
 
n 
 
  
 
3) whereas IL-12
p35 mRNA was induced to a lesser degree ([2
 
{
 
   
 
CT}
 
]:
364 
 
 
 
 164, 
 
n 
 
  
 
3). Simultaneous addition of increasing
concentration of 
 
Bet
 
.-APE lead to a dose-dependent inhibi-
tion of IL-12 p40 mRNA expression (Fig. 3 B). In contrast,
 
Bet
 
.-APE stimulation seemed to enhance the LPS-induced
IL-12 p35 mRNA (Fig. 3 B). These results suggest that 
 
Bet.-
 
APE–dependent inhibition of IL-12 p70 release is likely to
be regulated at the level of IL-12 p40 mRNA expression.
To rule out IL-10 as an autocrine inhibitor of IL-12 pro-
duction (28) DCs were stimulated with LPS and 
 
Bet
 
.-APE in
the presence or absence of neutralizing anti–IL-10 mAb (10
 
 
 
g/ml; R&D Systems). Although IL-10 neutralizing mAb
restored the inhibition of IL-12 release induced by exoge-
nous IL-10 (10 ng/ml; R&D Systems) back to normal, it did
not restore IL-12 production inhibited by 
 
Bet
 
.-APE (Fig. 3
C). To exclude effects of endogenous prostaglandins such as
PGE
 
2
 
, DCs were stimulated in the presence of the cyclooxy-
genase inhibitor indomethacin (25 
 
 
 
g/ml). Inhibition of DC
cyclooxygenase did not reverse the inhibitory effects of 
 
Bet
 
.-
APE, suggesting that the observed inhibition was indepen-
dent of endogenous prostaglandin production (Fig. 3 D).
Aqueous extracts of pollen grains from a variety of different
plants such as alder, hazel, lilac, mapel, and mugwort displayed
similar inhibitory activity on LPS-induced DC IL-12 produc-
tion (Fig. 3 E), although IL-6 release was not significantly af-
fected, suggesting that the observed immunomodulatory activ-
ity is not restricted to birch pollen but rather a more general
phenomenon shared by pollen grains from different species.
 
Bet.
 
-APE exposure shifts DC polarizing capacity 
from Th1 to Th2
 
The inhibitory effects of 
 
Bet
 
.-APE on DC IL-12 production
prompted us to analyze the phenotype of primary T cell re-
sponses induced by DCs matured in the presence of 
 
Bet
 
.-
APE. Naive allogeneic T cells primed by LPS-matured DCs
differentiated into Th1 lymphocytes with characteristic pro-
duction of large amounts of IFN-
 
 
 
 and low levels of IL-4
(Fig. 4). In contrast, DCs activated by LPS in the presence of
Figure 3. Bet.-APE inhibit DC IL-12 but not IL-6 production. (A) 
DCs were stimulated with LPS (100 ng/ml) in the presence of increasing 
concentrations of Bet.-APE. After 24 h IL-12 p70, IL-6, TNF , and IL-10 
concentrations were determined in culture supernantants. Data are 
presented as percentage of LPS-induced cytokine production in order to 
equalize donor specific variabilities (IL-12 p70 x   3,599  1,446 pg/ml,
n   6; IL-6 x  13,069   7,358 pg/ml, n   6; TNF  x   3,068;   440 pg/
ml, n   5; IL-10: x   343   149 pg/ml, n   5). Bet.-APE reduce LPS-
induced IL-12 p40 but not IL-12 p35 mRNA levels. (B) Immature DCs were 
stimulated for 6 h with LPS in presence of increasing concentrations of 
Bet.-APE. Quantitative IL-12 p40 and p35 mRNA analysis was performed. 
Data is shown as percentage of LPS-induced IL-12 p40 mRNA ([2{   CT}]: 
1,149   518, mean   SEM, n   3) or IL-12 p35 mRNA ([2{   CT}]: 364   
164, mean   SEM, n   3) expression. Bet.-APE–induced inhibition of DC 
IL-12 release is independent of autocrine IL-10 or endogeneous cyclooxy-
genase products. (C and D) DC stimulations were performed in the pres-
ence of IL-10–neutralizing antibodies (10  g/ml; C) or a cyclooxygenase 
inhibitor (25  M indomethacine; D). Data is presented as percentage 
(mean   SEM) of IL-12 p70 production induced by LPS (C: IL-12 p70: x   
2,481   416 pg/ml; n   4; D: IL-12 p70 x   4,126   326 pg/ml; n   3). 
APE from different species display similar effect on DC IL-12 and IL-6 
production. (E) DCs were stimulated with LPS (100 ng/ml) in the presence 
of increasing concentrations of APE generated from different pollen 
species. After 24 h, IL-12 p70 and IL-6 levels were determined in culture 
supernantants (IL-12 p70 x   1,477   426 pg/ml, n   3; IL-6 x  
10,776   1,463 pg/ml, n   3).IMMUNOMODULATORY PHYTOPROSTANES FROM POLLEN | Traidl-Hoffmann et al. 630
Bet.-APE displayed a dramatically reduced capacity to in-
duce IFN- –producing Th1 cells and a markedly enhanced
capacity to induce IL-4–producing Th2 cells. The Bet.-
APE–induced shift of a primarily Th1-dominated response
to a primarily Th2-dominated response was comparable to
that obtained under maximal Th2-polarizing condition, i.e.,
when DCs where stimulated with LPS in the presence of
PGE2 and neutralizing anti–IL-12 mAb was added at the be-
ginning of the MLR (Fig. 4 and Table I). The Bet.-APE–
induced shift from a Th1- to a Th2-dominated immune re-
sponse could partially be restored, when exogenous IL-12
was added at the beginning of the DC–T cell coculture (Fig.
4), indicating that indeed inhibition of the DC IL-12 pro-
duction by Bet.-APE plays a crucial role in the observed de-
viation of the immune response. However, addition of ex-
ogenous IL-12 (at concentration exceeding those measured
in DC cultures) was not able to restore the response com-
pletely, suggesting that besides IL-12 other Th1-driving me-
diators may be inhibited by exposure of DCs to Bet.-APE. In
contrast, when IL-4–neutralizing antibodies were added at
the beginning of the T cell–DC coculture (Fig. 4 B) induc-
tion of Th2 cells was almost completely abrogated, demon-
strating that the Th2-polarizing effect of Bet-APE–treated
DCs was clearly IL-4 dependent.
Figure 4. DCs matured in the presence of Bet.-APE display reduced 
Th1- and increased Th2-polarizing capacity. (A) DCs were left un-
treated or stimulated with Bet.-APE (3 mg/ml) in the presence or absence 
of LPS (100 ng/ml). After 24 h DCs were washed and cocultured with 
CD4 CD45RA  allogenic T cells (DC/T cell ratio 1:4) that were expanded 
for 12 d in the presence of IL-2. T cell polarization was determined by 
analyzing intracellular IFN-  and IL-4 accumulation via flow cytometry 
after restimulation with PMA and ionomycin in the presence of brefeldin A 
during the last 2 h of stimulation. To address, if the Bet.-APE–dependent 
Th2 polarization could be reverted by exogenous IL-12, hrIL-12 (10 ng/ml) 
was added at the beginning of the coculture of Bet.-APE/LPS-treated DCs 
and T cells. Representative experiment of n   3–6 (compare Table I). To 
explore the role of IL-4 in the Th2 polarization induced by Bet.-APE–treated 
DCs, IL-4–neutralizing antibodies (10  g/ml) were added at the beginning 
of the DC/T cell coculture. Representative experiment of n   3.
Figure 5. Analysis of phytoprostanes in Bet.-APE. Representative 
selected ion monitoring GC–NCI–MS traces of phytoprostanes from birch 
pollen extracts are shown. (A-C) PPE1, PPA1, and PPB1 were extracted, 
purified, and analyzed as their corresponding pentafluorobenzyl ester, 
trimethylsilyl ether PPB1 derivatives. (A) Endogenous PPE1 derivatives are 
identified in the m/z 379 ion current chromatogram and quantitated 
against the [18O]PPE1 internal standard in the m/z 381 ion current chro-
matogram. (B) During sample processing, PPA1 isomerize into the thermo-
dynamically more stable PPB1 isomers. Thus, the sum of endogenous PPA1 
and PPB1 derivatives are identified in the m/z 379 ion current chromato-
gram and quantitated against the [18O]PPB1 internal standard in the m/z 
381 ion current chromatogram. (C) Endogenous PPF1 derivatives are 
identified in the m/z 545 ion current chromatogram and quantitated 
against the [18O]3PPF1 internal standard in the m/z 551 ion current 
chromatogram. (D) Prostaglandin and phytoprostane structures. Prosta-
glandins E1, B1, and F1  (PGE1, PGB1, and PGF1 , respectively) are derived 
from 8,11,14-eicosatrienoic acid via a cyclooxygenase pathway that is 
present in mammals but not in plants. E1-, B1-, and F1-phytoprostanes 
(PPE1, PPB1, and PPF1, respectively) are formed nonenzymatically via free 
radical intermediates. Phytoprostanes, derived from  -linolenic acid, 
occur in plants but not in mammals that lack this fatty acid. Two regioiso-
meric phytoprostanes (types I and II) of each phytoprostane family are 
present as racemates in plants due to their nonenzymatic formation.JEM VOL. 201, February 21, 2005 631
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Bet.-APE contain substantial amounts of phytoprostanes
Previously it has been shown that various classes of prosta-
glandin-like compounds, the phytoprostanes, apparently oc-
cur ubiquitously in plants (23). Notably, exceptionally high
levels of F1-phytoprostanes (PPF1) have been observed in or-
ganic extracts of birch pollen (21). In an attempt to identify
potential candidates responsible for the observed effects of
Bet.-APE, we quantified levels of phytoprostanes present in
Bet.-APE by NCI GC-MS (Fig. 5, A–C and Table II). PPF1
levels in pollen released in aqueous buffer (Bet.-APE) were
2.25  g/g pollen. In addition, A1/B1- and E1-phytoprostanes
were detected in Bet.-APE. Interestingly, PPE1 levels were
found to be eightfold more abundant, whereas concentra-
tions of PPA1/B1 were found to be threefold less abundant as
compared with PPF1 (Table II).
E1-Phytoprostanes inhibit LPS-induced DC IL-12 p70
production and augment DC’s capacity to induce Th2 re-
sponses. Various prostaglandins have been reported to mod-
ulate human DC function and cytokine profile (14, 29). The
structural similarity of  -linolenic acid–derived phytopros-
tanes and prostaglandins prompted us to analyze whether
phytoprostanes identified in Bet.-APE (PPE1, PPF1, and
PPA1/PPB1) showed similar effects on human DCs. For this
purpose DCs were activated by LPS in the presence or ab-
sence of phytoprostanes or PGE2 over a wide range of con-
centrations (Fig. 6). As reported previously, PGE2 dose
dependently inhibited the LPS-induced IL-12 p70 release
(14), whereas LPS-induced IL-6 production remained un-
changed. PPF1 and PPB1 did neither affect the LPS-induced
IL-12 p70 production nor the LPS-induced IL-6 produc-
tion. However, PPE1 markedly inhibited the LPS-induced
IL-12 p70 production, without affecting the IL-6 produc-
tion. The inhibitory effect of PPE1 on DC IL-12 production
was only observed when DCs were activated (e.g., by LPS)
whereas in the absences of activation signals PPE1 alone did
neither modulate the basal IL-12 production, nor the out-
come of the DC induced Th cell response. The inhibition of
IL-12 release by PPE1 was not due to cytotoxic effects, as
determined by propidium iodide exclusion. In contrast to
the effect on LPS-induced IL-12 production none of the
phytoprostanes tested had any significant effect on LPS-
induced DC maturation (unpublished data). In addition to
Table I. Bet.-APE and E1-phytoprostanes induce Th2 polarization
DC stimulation IL-4 b IFN-  c IL-4   IFN-  d IL-4/IFN-  ratioe n
Medium 13.8   6.4 37.0   3.3g 8.8   0.4 0.36   0.05 6
LPS 12.3   2.4 59.2   3.7f 8.3   0.8 0.22   0.05f 6
LPS   PGE2
a 38.8   6.5 15.5   4.2 9.7   2.1 2.5   0.18 6
LPS   Bet.-APE 24.3   3.8f,g 25.8   4.1f,g 8.0   2.0 1.06   0.18f,g 6
APE 22.3   2.4 36.9   2.01 9.7   0.5 0.6   0.09 6
LPS 15.7   3.1 53.7   4.3 10.5   2.1 0.30   0.17 3
LPS   PPE1 33.3   0.3f,g 36.7   2.6g 14.3   3.3 0.92   0.06f,g 3
LPS   PPF1 15.0   0.5 58.7   6.1 10.7   0.3 0.27   0.04 3
LPS   PPB1-I 18.7   3.5 55.3   6.3 11.3   1.2 0.38   0.12 3
LPS   PPB1-II 19.0   2.6 58.0   6.0 15.7   2.8 0.35   0.08 3
aTo obtain a maximal Th2 polarization  IL-12 (10 mg/ml) was added at the beginning of the DC–T cell coculture.
bPercentage of IL-4–producing allogeneic CD4 T cells 12 d after activation by differently activated human DC (see Materials and methods; as determined by intracellular cytokine 
staining, mean   SEM).
cPercentage of IFN- –producing allogeneic CD4 T cells.
dPercentage of double positive (IL-4 and IFN- ) cells.
eRatio of the percentage of IFN- – and IL-4–producing cells. 
fP   0.05 as compared to medium control.
gP   0.05 as compared to LPS stimulation.
Table II. Concentrations of phytoprostanes in Bet.-APE
Mol Wt
Concentration in 
Bet.-APEa
(10 mg/ml)
Concentrationa
( g/g pollen) n
PPE1 326 543.6   41.1 nM 17.72   1.34  g/g 3
PPF1 328 68.6   1.5 nM 2.25   0.05  g/g 3
PPA1/B1 308 23.8   3.5 nM 0.74   0.11  g/g 3
aPhytoprostanes were quantified in 10 mg/ml Bet.-APE by GC-NCI-MS (see Materials 
and methods).
Figure 6. E1-Phytoprostanes inhibit DC IL-12 production. Phyto-
prostanes (PP) identified in Bet-APE were analyzed with regard to their 
effect on DC cytokine production. DCs were stimulated with LPS (100 ng/
ml) in the presence of different phytoprostanes (PPE1, PPF1, PPB1-I, and 
PPB1-II) in nontoxic concentrations (10 7 M  3   10 6 M). Data is 
presented as percentage (mean   SEM) of IL-12 p70 (left) or IL-6 (right) 
production induced by LPS (IL-12 p70 x   1,587   397 pg/ml; IL-6 x   
21,214   5,422 pg/ml; n   5).IMMUNOMODULATORY PHYTOPROSTANES FROM POLLEN | Traidl-Hoffmann et al. 632
phytoprostanes, we recently demonstrated that Bet.-APE con-
tain substantial quantities of monohydroxylated derivatives
of  -linolenic and linoleic acid, such as 9- and 13-hydroxy-
octadecatrienoate as well as 9- and 13-hydroxyoctadeca-
dienoate (25, 26). Since some of these lipids have been
suggested to inhibit the IL-12 production in human macro-
phages (30) we analyzed their effect on human DCs. Inter-
estingly, none of these mediators (10 11–10 5 M) lead to an
inhibition of the LPS-induced IL-12 p70 release of human
DCs (unpublished data). The PPE1-dependent inhibition of
DC IL-12 production prompted us to analyze the effects
of various phytoprostanes on Th1–Th2 polarizing capacity
of DCs. Presence of PPE1 but not PPF1 or PPB1 during
LPS-induced DC activation lead to the generation of DCs
that displayed an increased capacity to induce Th2 polariza-
tion in naive T cells, as determined by intracellular cytokine
staining (Table I).
DISCUSSION
Pollen grains are one of the most common inducers of allergic
symptoms. Upon contact with mucosal surfaces of the upper
respiratory tract, pollen grains rapidly release proteins/aller-
gens into the aqueous phase. On the basis of a genetic suscep-
tibility atopic individuals develop allergen-specific Th2-biased
immune responses that ultimately lead to clinical manifesta-
tions of IgE-mediated hypersensitivity. Although the biology
of Th2 cells in the effector phase of allergy is well understood,
little is known about the mechanisms that control the initial
Th2 polarization in response to exogenous allergens.
We recently demonstrated that pollen in addition to lib-
erating protein allergens rapidly release various bioactive lip-
ids into the aqueous phase (24–26). These pollen-associated
lipid mediators (PALMs) were shown to stimulate and attract
cells of the innate immune system, such as neurophil and
eosinophil granulocytes (25, 26). Here, we describe the effect
of PALMs on the activation and functional maturation of hu-
man DCs. In addition, we demonstrate that Bet.-APE and
certain phytoprostanes identified in Bet.-APE modulate the
function of human DCs in a fashion that results in a preferen-
tial induction of Th2-dominated adaptive immune responses.
Activation of DCs with LPS depleted by Bet.-APE (LPS
under the detection limit of the LAL test) resulted in moder-
ate DC activation as documented by selective up-regula-
tion of HLA-DR surface expression. When DCs were stimu-
lated simultaneously with LPS plus Bet.-APE, the presence
of Bet.-APE resulted in an additional up-regulation of CD80,
CD86, and HLA-DR surface expression. At a functional
level Bet.-APE–induced DC maturation resulted in an en-
hanced allostimmulatory activity as demonstrated by en-
hanced proliferative responses of naive allogeneic T cells. In
addition, Bet.-APE treatment induced a dose-dependent in-
hibition of the LPS or CD40L induced IL-12 p70 produc-
tion of DCs, whereas IL-6, IL-10, and TNF  production
was not impaired. Thus, water-soluble factors released from
pollen grains are capable to selectively modulate various DC
functions, including the inhibition of activation-induced IL-
12 release from human DCs. The reduced IL-12 production
was confirmed at mRNA level, demonstrating that regula-
tion occurred predominantly at the level of IL-12 p40 rather
than IL-12 p35.
Maturation of DCs is stimulated by factors signaling tissue
danger such as microorganisms, dying cells, or proinflamma-
tory cytokines. Recently, a variety of factors has emerged that
can limit DC maturation. For example intracellular cAMP-
elevating agents, such as PGE2, inhibit IL-12 and TNF  and
enhance IL-10 expression by LPS-stimulated DCs (14, 31).
In contrast, IL-10, glucocorticoids, and vitamin D3 interfere
with DC maturation as a whole by blocking the up-regula-
tion of presenting and costimulatory molecules (13, 32, 33).
Bet.-APE seemed to act independently of the above-cited
mechanisms because its activity was not affected by indo-
methacin or neutralization of endogenous IL-10.
Recently a series of isoprostanes with the characteristic
prostaglandin ring systems was discovered in plants and des-
ignated phytoprostanes (19). Phytoprostanes are formed via
autooxidation, which is initiated by free radical attack of
 -linolenic acid yielding a linolenate radical that readily oxi-
dizes and cyclizes to two regioisomeric, prostaglandin G–like
compounds (34). In vivo, PPG1 may be either reduced to
PPF1 or converted to PPE1, which itself may be dehydrated
and isomerized to PPB1 (19, 21).
In the present study we demonstrate for the first time
that nonenzymatically formed phytoprostanes such as PPE1,
PPF1, and PPB1 are present in aqueous pollen extracts in
nanomolar concentrations as identified and quantified by
NCI GC-MS (19, 21). Levels of PPF1 in organic extracts
of birch pollen appear to be approximately 15 times more
abundant in organic as compared with aqueous extracts (21).
These differences might reflect different extraction efficien-
cies as well as varying concentrations in pollen from different
sources. A survey of PPF1 levels in fresh pollen from individ-
ual betula pendula L. trees and different birch species extracted
with organic solvents revealed that levels vary greatly and
range from 2 to 33  g/g pollen (unpublished data). A similar
variance is expected for PPE1 levels. Phytoprostane levels in
organic extracts reflect lipid peroxidation in pollen, and may
only be of limited relevance for estimates of natural exposure
levels on the mucus membranes. In contrast, analysis of phy-
toprostanes levels spontaneously released into the aqueous
phase of the buffer used in this study, more closely mimics
physiological exposure conditions.
PPE1, PPF1 and PPB1 were tested in their capacity to
modulate the IL-12 production of human DCs. Interestingly,
only PPE1 but not PPF1 or PPB1 inhibited the LPS or CD40-
induced IL-12 production. Although Bet.-APE induced a
functional and phenotypical maturation, none of the phyto-
prostanes tested had any significant effect on DC maturation
(unpublished data). The modulatory effect of PPE1 on DC IL-
12 production and the ensuing T cell response was dependent
on the presence of a maturation signal such as LPS or CD40
ligation. The receptors and signal transduction pathways in-
volved in these mechanisms are currently under investigation.JEM VOL. 201, February 21, 2005 633
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It is generally accepted that DCs instruct the immune sys-
tem to initiate an Ag-specific response by providing naive Th
cells with signal 1 (TRC triggering) and signal 2 (costimula-
tion). In addition, it has recently been suggested that imma-
ture DCs in peripheral non lymphoid tissue can adopt differ-
ent Th1- or Th2-promoting effector function, depending on
the tissue- and/or pathogen-type context of their activation
(14). This DC-dependent component of the initial polariza-
tion of naive T cells (signal 3) was suggested to depend on
pathogen-derived or -induced endogenous factors present in
the local microenvironment at the time of antigen encounter.
Our study demonstrates that this signal 3 can also be modu-
lated by exogenous mediators such as phytoprostanes that are
released from (under normal circumstances nonpathogenic)
pollen grains upon contact with the airway mucosa.
Clearly, any extrapolation of these effects to the in vivo
situation would partly depend on the expected concen-
tration of pollen-derived lipids in the nasal or bronchial
microenvironment. As demonstrated previously, concentra-
tions of linolenic and linoleic acid in pollen are high (25, 26)
and we assume that during pollen season the upper respira-
tory tract mucosa is exposed to biologically relevant concen-
tration of various oxidized derivatives of these fatty acids.
The effects of in vivo exposure to PALMs are currently un-
der investigation.
Collectively, our data provide compelling evidence for
the role of exogenous pollen-derived phytoprostanes in the
decision-making process of DCs. We suggests that DCs that
have been conditioned by PALMs, such as E1-phytopros-
tanes will provide one of the initial signals driving the devel-
opment and perpetuation of Th2-dominated immune re-
sponse in pollen allergy.
MATERIALS AND METHODS
Reagents and Abs. Human rIL-4 was obtained from Promocell, human
rGM-CSF from Essex, soluble CD40L (sCD40L) from Alexis. Purified LPS
(Escherichia coli K235-derived LPS;  0.008% protein) was provided by Dr.
Stephanie Vogel (University of Maryland, College Park, MD). FITC- or PE-
conjugated anti–HLA-DR, anti-CD1a, anti-CD86, anti-CD80, anti-CD83,
anti-CD1a, anti–IL-4, and anti–IFN-  mAb were purchased from Becton
Dickinson, anti-CD4 and anti-CD45RA microbeads from Miltenyi Biotech.
Preparation of Bet.-APE. Birch pollen grains (Betula alba L.) were ob-
tained from Allergon. Bet.-APE were generated by incubation of pollen
grains in RPMI 1640 (30 mg/ml) for 30 min at 37 C followed by centrifu-
gation (20 min at 3,345 g) and sterile filtration (0.2  m; 24). LPS was mea-
sured by LAL assay (Cambrex Bio Science). To deplete LPS, Bet.-APE were
eluted over polymyxin B columns (Pierce Chemical Co.) leading to LPS
concentrations below the detection limit of the assay ( 0.05 EU/ml). LPS-
depleted Bet.-APE was used for subsequent experiments.
Monocyte-derived DCs. Healthy, nonatopic blood donors were charac-
terized by screening for total and specific IgE for common allergens as de-
scribed recently (25). Monocyte-derived DCs were prepared from peripheral
blood of healthy individuals, as described recently (35). In brief, adherent
PBMC ( 90% pure CD14  cells) were cultured at 106 cells/ml in RPMI
1640 supplemented with 1 mM sodium pyruvate, 0.1 mM nonessential amino
acids, 2 mM L-glutamine, 0.05 mM 2-ME, 100 U/ml penicillin, and 100  g/
ml streptomycin (all from Life Technologies) supplemented with 10% FBS,
500 U/ml human rGM-CSF (Essex Pharma) and 500 U/ml human rIL-4
(Promocell; complete DC medium) at 37 C under 5% CO2. At day 5 cells
( 95% CD1a , CD14 ) were harvested and recultured in complete DC me-
dium for 24 h at 37 C with or without indicated stimuli in the presence or ab-
sence of LPS (100 ng/ml) or soluble CD40L (1  g/ml; Alexis) followed by
addition of a cross-linker (1  g/ml). Aliquots of DC culture supernatants were
assayed for IL-12 p70, IL-6, IL-10, and TNF  by two site ELISAs using anti-
bodies from BD Biosciences as described previously (36).
Flow cytometry of DCs. Surface expression of DC maturation markers
was analyzed using multicolor flow cytometry as described recently (37). In
brief, DCs (either untreated or stimulated for 24 h with LPS in the presence
or absence of pollen extracts or phytoprostanes) were harvested, washed,
and suspended in cold PBS containing 5% FCS and 0.02% NaN3, and then
serially incubated with saturating concentrations of FITC-conjugated mAb,
and PE-conjugated mAb. Matched isotype control mAb were used in con-
trol samples. Stained cells were analyzed using a FACS Calibur flow cytom-
eter equipped with CellQuest software (Becton Dickinson). Propidium io-
dide-permeable (nonviable) cells were excluded from analysis.
MLR. Human CD4 , CD45RA  T cells were purified from nonadherent
PBMC from healthy nonatopic donors using magnetic cell sorting column
separators with anti-CD4 and anti-CD45RA microbeads (Miltenyi Biotec).
Differently stimulated DCs (24 h) were washed and cocultured with mag-
netic cell sorting–purified allogeneic naive CD4 , CD45RA  T cells (105
cells/well) in complete RPMI with 5% human serum. Cell proliferation
was quantified using a BrdU cell proliferation ELISA (Amersham Bio-
sciences). To analyze T cell polarization, DC/T cell cocultures were incu-
bated in a 96-well plate at a DC/T ratio of 1:4 and T cells were subse-
quently expanded in 24-well plates in medium supplemented with IL-2 (20
U/ml; Chiron Corp.). LPS-activated DCs (24 h) were harvested, washed
twice, and used for priming to generate Th1-polarized T cells (“Th1 con-
trol”). Th2-polarized T cells (“Th2 control”) were generated by using DCs
that were activated (24 h) with LPS in the presence of PGE2 (10 6 M;
Qbiogene). In addition, neutralizing anti-IL-12 mAb (10  g/ml; BD Bio-
sciences) was added at the beginning of the DC/T cell coculture in order to
generate a maximal Th2 polarization.
Intracellular cytokine staining. After 12 d of culture, T cells were re-
stimulated with PMA (20 ng/ml; Sigma-Aldrich) and ionomycin (1  g/ml;
Sigma-Aldrich) for 6 h and examined for intracellular IFN-  and IL-4 accu-
mulation. To prevent cytokine secretion, Brefeldin A (10  g/ml; Sigma-
Aldrich) was added for the final 2 h. T cells were fixed (2% paraformalde-
hyde), permeabilized (0.5% saponin), and stained with FITC-conjugated
mouse anti–IFN-  and PE-conjugated rat anti–IL-4 mAb or isotype-matched
control mAb and analyzed by flow cytometry as described previously (38).
Quantitative mRNA analysis. Total RNA was extracted from purified
DCs after a 6-h incubation with the indicated stimuli using peqGOLD
RNAPure buffer (Peqlab). RNA was reverse transcribed using random
hexamer primers (Roche). PCR reactions for IL-12 p40 and p35 (Assay on
Demand; Applied Biosystems) were run on an ABI PRISM 7700 Sequence
Detection System device (Applied Biosystems) using the following pro-
gram: 10 min at 94 C followed by 40 cycles of 15 s at 95 C, and 60 s at
55 C. 18 s RNA served as housekeeping gene.
Analysis of PPE1, PPA1/B1, and PPF1 by NCI GC-MS. Aqueous
extracts (20 ml) of birch pollen (200 mg) were treated with 10 ml of a satu-
rated NaCl solution in water containing 0.05% butylated hydroxytoluene
(wt/vol), 20 mg of triphenylphosphine, 0.2 ml of 1 M citric acid, and isoto-
pically labeled phytoprostane standards. Phytoprostanes were extracted with
diethyl ether, purified, derivatized, and analyzed by NCI GC-MS as de-
scribed previously (21).
Preparation of PPE1, PPB1, and PPF1. Racemic E1- and F1-phyto-
prostanes were prepared by autoxidation of  -linolenic acid and purified asIMMUNOMODULATORY PHYTOPROSTANES FROM POLLEN | Traidl-Hoffmann et al. 634
described previously (19, 21). B1-Phytoprostanes were obtained by base-
catalyzed isomerization of E1-phytoprostanes (21).
Statistic. Student’s paired t test was used to compare groups and ratios of
IL-4– or IFN- –producing T cells induced by differently stimulated DCs.
P   0.05 was considered significant.
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